Japan, Feb. 27 -- CENTESSA PHARMACEUTICALS UK LTD has got intellectual property rights for 'BINDING AGENT.' Other related details are as follows:
Application Number: JP,2024-167571
Category (FI): A61K31/7088,A61K39/395@C,A61K39/395@D,A61K39/395@L,A61K39/395@N,A61K45/00,A61K47/68,A61K48/00,A61P1/00,A61P1/04,A61P11/00,A61P11/06,A61P13/12,A61P17/02,A61P17/06,A61P19/02,A61P25/00,A61P29/00,A61P35/00,A61P37/02,A61P37/06,A61P43/00,121,A61P5/14,A61P5/16,A61P7/00,A61P7/06,A61P9/00,A61P9/10,A61P9/10,101,C07K16/28,C07K16/46,C12N1/15,C12N1/19,C12N1/21,C12N15/13,C12N15/63@Z,C12N5/10,C12P21/08
Stage: PROBLEM TO BE SOLVED: To provide antibody molecules and antigen-binding portions thereof that specifically bind to CD47 (differentiation cluster 47, also...